Advance care planning rose dramatically among minorities through intervention, study finds
By
Alicia Lasek
Feb 25, 2022
Older patients were more likely to record their end-of-life care wishes when they watched educational videos and received clinical counsel during the pandemic, a new study finds. Documentation among Black...
FDA authorizes monoclonal antibody that tackles omicron
By
Alicia Lasek
Feb 15, 2022
Bebtelovimab is greenlit for treatment of mild to moderate COVID-19 in patients at high risk of severe disease. The move comes amid a federal push to increase supply of effective therapies.
Loneliness closely linked to 10-year dementia risk
By
Alicia Lasek
Feb 14, 2022
Loneliness triples the odds of dementia in those for whom risk would otherwise be relatively low based on age and genetics, researchers say.
CMS shares LTC booster data; coverage among residents meets national average
By
Alicia Lasek
Feb 10, 2022
Nursing home booster vaccination data is now available on the Medicare.gov Care Compare website as part of CMS’s effort to help increase facility vaccination coverage, the agency said Wednesday.
Study unveils ‘silent epidemic’ of loneliness among older women during pandemic
By
Alicia Lasek
Feb 09, 2022
Data from the Women’s Health Initiative show that rates of loneliness in women aged 70 and older have increased during the pandemic, with 19% reporting severe troubles, investigators say.
Night shift linked to insomnia and stress symptoms in nurses, study finds
By
Alicia Lasek
Feb 04, 2022
The effects of poor sleep shouldn’t be overlooked in nurses — especially those who work night shifts, investigators say.
New COVID-19 test kits promised as LTC operators contend with shortages, slow PCR results
By
Alicia Lasek
Feb 03, 2022
Five million Celltion brand rapid tests will be shipped over a five-week period to facilities as they contend with testing supply shortages and slow lab turnaround times.
After 20 years on the market, AbbVie’s dry-eye drug Restasis to be available as generic
By
Alicia Lasek
Feb 03, 2022
Dry eyes affect nearly 19% percent of adults aged 75 years and older, according to data from a national survey.
U.S. gives green light to Moderna’s COVID-19 vaccine
By
Alicia Lasek
Feb 01, 2022
“Spikevax” is the second COVID-19 mRNA vaccine to receive full FDA approval, following Pfizer-BioNTech’s Comirnaty in September.
Clinical briefs for Thursday, Jan. 27
By
Alicia Lasek
Jan 27, 2022
CMS: Only fully vaccinated surveyors should be part of on-site survey teams … CMS begins posting more staffing and turnover data … Senators sponsor bipartisan bill to probe handling of U.S. pandemic...